Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press Careers
Contact Us
Company Logo
Reports Store
Top 11 Hot Markets
NEW
 Biologics Hot Titles 2025
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services
Recreation Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare
Mega Trends
3D Printing 5G and 6G Technologies Advanced Analytics and Predictive Analytics Alternative Proteins (Plant-Based, Cultured Meat) Artificial Intelligence (AI) Autonomous Systems Augmented Reality (AR) and Virtual Reality (VR) Big Data Analytics
Blockchain, Cryptocurrencies and Decentralized Finance (DeFi) Biotechnology Cloud Computing Cybersecurity Digital Therapeutics Digitalization E-commerce and Digital Retail Edtech and E-Learning
Electric Mobility ESG (Environmental, Social, Governance) Investments Fintech (Digital Payments, Neobanking, Open Banking) Healthtech and Telehealth Industry 4.0 and 5.0 Internet of Things (IoT) Nanotechnology Precision Medicine and Genomics
Quantum Computing Regtech and Insurtech Robotics Smart Homes and Buildings Space Economy Sustainability Sustainable Consumer Products Wearable Technology
Market Intelligence Platform
About GMM Global Forecast
NEW
 Real Growth Rate Analysis Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal

Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Inactivated Influenza Vaccine Market Report 2025

Inactivated Influenza Vaccine Global Market Report 2025 - By Type Of Vaccine (Trivalent Inactivated Influenza Vaccine (TIIV), Quadrivalent Inactivated Influenza Vaccine (QIIV)), By Application (Children, Adolescence, Adults, Elderly), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Public Health Clinics), By End-User (Healthcare Providers, Individuals, Government Organizations, Pharmaceutical Companies) - Market Size, Trends, And Global Forecast 2025-2034

Inactivated Influenza Vaccine Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Inactivated Influenza Vaccine Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures

Market Insights

Related Reports

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Inactivated Influenza Vaccine Market?

Inactivated influenza vaccine refers to a type of flu vaccine that contains viruses that have been killed or inactivated. It works by prompting the immune system to produce antibodies against the influenza virus. This vaccine is administered via injection to help prevent seasonal influenza infections.

The main types of vaccines in the inactivated influenza vaccine market are trivalent inactivated influenza vaccine (TIIV) and quadrivalent inactivated influenza vaccine (QIIV). Trivalent inactivated influenza vaccine refers to a flu shot containing three killed virus strains, two influenza A and one influenza B, to protect against seasonal influenza. The various applications include children, adolescence, adults, and the elderly and are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and public health clinics. The different end-users encompass healthcare providers, individuals, government organizations, and pharmaceutical companies.

Inactivated Influenza Vaccine Market Size and growth rate 2025 to 2029: Graph
Share Share

What Is The Inactivated Influenza Vaccine Market Size 2025 And Growth Rate?

The inactivated influenza vaccine market size has grown strongly in recent years. It will grow from $6.62 billion in 2024 to $7.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased seasonal influenza outbreaks, government vaccination campaigns, rising elderly population, improved public health awareness, and expanded healthcare infrastructure.

What Is The Inactivated Influenza Vaccine Market Growth Forecast?

The inactivated influenza vaccine market size is expected to see strong growth in the next few years. It will grow to $9.99 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for quadrivalent vaccines, expanding immunization programs, growing focus on pandemic preparedness, technological advancements in vaccine production, and increasing global vaccine access. Major trends in the forecast period include a shift toward cell-based vaccine production, growing adoption of adjuvanted formulations, integration of influenza vaccines with COVID-19 boosters, rising demand in emerging markets, and personalized vaccine development strategies.

Book your 30 minutes free consultation with our research experts

Contact Us

How Is The Inactivated Influenza Vaccine Market Segmented?

The inactivated influenza vaccine market covered in this report is segmented –

1) By Type Of Vaccine: Trivalent Inactivated Influenza Vaccine (TIIV), Quadrivalent Inactivated Influenza Vaccine (QIIV)

2) By Application: Children, Adolescence, Adults, Elderly

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Public Health Clinics

4) By End-User: Healthcare Providers, Individuals, Government Organizations, Pharmaceutical Companies

Subsegments:

1) Trivalent Inactivated Influenza Vaccine (TIIV): Egg-based Trivalent Inactivated Influenza Vaccine, Cell-based Trivalent Inactivated Influenza Vaccine, Adjuvanted Trivalent Inactivated Influenza Vaccine, High-dose Trivalent Inactivated Influenza Vaccine

2) Quadrivalent Inactivated Influenza Vaccine (QIIV): Egg-based Quadrivalent Inactivated Influenza Vaccine, Cell-based Quadrivalent Inactivated Influenza Vaccine, Adjuvanted Quadrivalent Inactivated Influenza Vaccine, Recombinant Quadrivalent Inactivated Influenza Vaccine, Pediatric Quadrivalent Inactivated Influenza Vaccine

What Is Driving The Inactivated Influenza Vaccine Market? Expansion Of Government Vaccination Programs Driving Growth Of The Market Due To Enhancing Public Health Awareness

The rising government vaccination programs are expected to propel the growth of the inactivated influenza vaccine market going forward. ?Government vaccination programs are expanding due to increasing public health awareness among populations, which leads to higher demand for immunization services and encourages governments to enhance vaccine accessibility and outreach initiatives. Government vaccination programs facilitate the administration of inactivated influenza vaccines by providing free or subsidized access to high-risk groups, ensuring equitable immunization coverage, and reducing the burden of seasonal influenza. For instance, in December 2023, the National Health Service, a UK-based government agency, initiated an NHS vaccine strategy for immunization goals. The strategy includes plans for community-based vaccination services, particularly targeting underserved and marginalized groups. Therefore, the rising government vaccination programs are driving the growth of the inactivated influenza vaccine market.

Who Are The Major Players In The Global Inactivated Influenza Vaccine Market?

Major companies operating in the inactivated influenza vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis International, GlaxoSmithKline plc, Viatris Inc., CSL, Zydus Lifesciences Limited, Sinovac Biotech Ltd., Bharat Biotech International Limited, Dalian Aleph Biomedical Co. Ltd., Hualan Biological Bacterin Co. Ltd, Changchun Biological, Jiangsu gdk Biotechnology Co., Ltd., KM Biologics, JoinHub Pharma, Pharmika India Private Limited.

What Are The Key Trends Of The Global Inactivated Influenza Vaccine Market? Focus On Quadrivalent Inactivated Influenza Vaccines To Enhance Protection And Vaccine Efficacy In The Market

Major companies operating in the inactivated influenza vaccine market are focusing on developing quadrivalent inactivated influenza vaccines to provide broader protection against four strains of the influenza virus. A quadrivalent inactivated influenza vaccine is a flu shot that protects against four different flu viruses. For instance, in February 2025, Zydus Lifesciences, an India-based pharmaceutical company, launched VaxiFlu-4, a quadrivalent inactivated influenza vaccine designed to offer seasonal protection against four new virus strains. VaxiFlu-4 provides broader protection by covering both influenza A and B strains, reducing the risk of vaccine mismatch. The vaccine aims to address seasonal flu outbreaks with improved immune response tailored to regional epidemiological patterns.

What Are Latest Mergers And Acquisitions In The Inactivated Influenza Vaccine Market? GSK Expands mRNA Capabilities With Acquisition Of Influenza Vaccine Rights From CureVac To Boost Pandemic Preparedness

In July 2024, GSK plc, a UK-based pharmaceutical company specializing in vaccines and biopharmaceuticals, acquired full rights to develop, manufacture, and commercialize mRNA-based influenza and COVID-19 vaccines from CureVac N.V. for an undisclosed amount. With this acquisition, GSK aims to accelerate its mRNA vaccine development, leveraging CureVac’s research to enhance seasonal flu and pandemic preparedness strategies. CureVac N.V. is a Germany-based biotechnology company focused on mRNA-based therapeutics, including vaccines for influenza and cancer immunotherapy.

What Is The Regional Outlook For The Global Inactivated Influenza Vaccine Market?

North America was the largest region in the inactivated influenza vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated influenza vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the inactivated influenza vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inactivated Influenza Vaccine Market?

The inactivated influenza vaccine market consists of sales of adjuvanted inactivated influenza vaccines, preservative-free inactivated influenza vaccines, cell-based inactivated influenza vaccines, egg-based inactivated influenza vaccines, pediatric inactivated influenza vaccines, high-dose inactivated influenza vaccines for older adults, prefilled syringe vaccines, and multidose vial vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Inactivated Influenza Vaccine Industry?

The inactivated influenza vaccine market research report is one of a series of new reports from The Business Research Company that provides inactivated influenza vaccine market statistics, including inactivated influenza vaccine industry global market size, regional shares, competitors with an inactivated influenza vaccine market share, detailed inactivated influenza vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the inactivated influenza vaccine industry. This inactivated influenza vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Inactivated Influenza Vaccine Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $7.21 billion
Revenue Forecast In 2034 $9.99 billion
Growth Rate CAGR of 8.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The inactivated influenza vaccine market covered in this report is segmented –
1) By Type Of Vaccine: Trivalent Inactivated Influenza Vaccine (TIIV), Quadrivalent Inactivated Influenza Vaccine (QIIV)
2) By Application: Children, Adolescence, Adults, Elderly
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Public Health Clinics
4) By End-User: Healthcare Providers, Individuals, Government Organizations, Pharmaceutical Companies Subsegments:
1) Trivalent Inactivated Influenza Vaccine (TIIV): Egg-based Trivalent Inactivated Influenza Vaccine, Cell-based Trivalent Inactivated Influenza Vaccine, Adjuvanted Trivalent Inactivated Influenza Vaccine, High-dose Trivalent Inactivated Influenza Vaccine
2) Quadrivalent Inactivated Influenza Vaccine (QIIV): Egg-based Quadrivalent Inactivated Influenza Vaccine, Cell-based Quadrivalent Inactivated Influenza Vaccine, Adjuvanted Quadrivalent Inactivated Influenza Vaccine, Recombinant Quadrivalent Inactivated Influenza Vaccine, Pediatric Quadrivalent Inactivated Influenza Vaccine
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis International, GlaxoSmithKline plc, Viatris Inc., CSL, Zydus Lifesciences Limited, Sinovac Biotech Ltd., Bharat Biotech International Limited, Dalian Aleph Biomedical Co. Ltd., Hualan Biological Bacterin Co. Ltd, Changchun Biological, Jiangsu gdk Biotechnology Co., Ltd., KM Biologics, JoinHub Pharma, Pharmika India Private Limited.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Inactivated Influenza Vaccine Market Characteristics

    3. Inactivated Influenza Vaccine Market Trends And Strategies

    4. Inactivated Influenza Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Inactivated Influenza Vaccine Growth Analysis And Strategic Analysis Framework

    5.1. Global Inactivated Influenza Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Inactivated Influenza Vaccine Market Growth Rate Analysis

    5.4. Global Inactivated Influenza Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Inactivated Influenza Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Inactivated Influenza Vaccine Total Addressable Market (TAM)

    6. Inactivated Influenza Vaccine Market Segmentation

    6.1. Global Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Trivalent Inactivated Influenza Vaccine (TIIV)

    Quadrivalent Inactivated Influenza Vaccine (QIIV)

    6.2. Global Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Children

    Adolescence

    Adults

    Elderly

    6.3. Global Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    Public Health Clinics

    6.4. Global Inactivated Influenza Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Healthcare Providers

    Individuals

    Government Organizations

    Pharmaceutical Companies

    6.5. Global Inactivated Influenza Vaccine Market, Sub-Segmentation Of Trivalent Inactivated Influenza Vaccine (TIIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Egg-based Trivalent Inactivated Influenza Vaccine

    Cell-based Trivalent Inactivated Influenza Vaccine

    Adjuvanted Trivalent Inactivated Influenza Vaccine

    High-dose Trivalent Inactivated Influenza Vaccine

    6.6. Global Inactivated Influenza Vaccine Market, Sub-Segmentation Of Quadrivalent Inactivated Influenza Vaccine (QIIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Egg-based Quadrivalent Inactivated Influenza Vaccine

    Cell-based Quadrivalent Inactivated Influenza Vaccine

    Adjuvanted Quadrivalent Inactivated Influenza Vaccine

    Recombinant Quadrivalent Inactivated Influenza Vaccine

    Pediatric Quadrivalent Inactivated Influenza Vaccine

    7. Inactivated Influenza Vaccine Market Regional And Country Analysis

    7.1. Global Inactivated Influenza Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Inactivated Influenza Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Inactivated Influenza Vaccine Market

    8.1. Asia-Pacific Inactivated Influenza Vaccine Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Inactivated Influenza Vaccine Market

    9.1. China Inactivated Influenza Vaccine Market Overview

    9.2. China Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Inactivated Influenza Vaccine Market

    10.1. India Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Inactivated Influenza Vaccine Market

    11.1. Japan Inactivated Influenza Vaccine Market Overview

    11.2. Japan Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Inactivated Influenza Vaccine Market

    12.1. Australia Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Inactivated Influenza Vaccine Market

    13.1. Indonesia Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Inactivated Influenza Vaccine Market

    14.1. South Korea Inactivated Influenza Vaccine Market Overview

    14.2. South Korea Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Inactivated Influenza Vaccine Market

    15.1. Western Europe Inactivated Influenza Vaccine Market Overview

    15.2. Western Europe Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Inactivated Influenza Vaccine Market

    16.1. UK Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Inactivated Influenza Vaccine Market

    17.1. Germany Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Inactivated Influenza Vaccine Market

    18.1. France Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Inactivated Influenza Vaccine Market

    19.1. Italy Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Inactivated Influenza Vaccine Market

    20.1. Spain Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Inactivated Influenza Vaccine Market

    21.1. Eastern Europe Inactivated Influenza Vaccine Market Overview

    21.2. Eastern Europe Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Inactivated Influenza Vaccine Market

    22.1. Russia Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Inactivated Influenza Vaccine Market

    23.1. North America Inactivated Influenza Vaccine Market Overview

    23.2. North America Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Inactivated Influenza Vaccine Market

    24.1. USA Inactivated Influenza Vaccine Market Overview

    24.2. USA Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Inactivated Influenza Vaccine Market

    25.1. Canada Inactivated Influenza Vaccine Market Overview

    25.2. Canada Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Inactivated Influenza Vaccine Market

    26.1. South America Inactivated Influenza Vaccine Market Overview

    26.2. South America Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Inactivated Influenza Vaccine Market

    27.1. Brazil Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Inactivated Influenza Vaccine Market

    28.1. Middle East Inactivated Influenza Vaccine Market Overview

    28.2. Middle East Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Inactivated Influenza Vaccine Market

    29.1. Africa Inactivated Influenza Vaccine Market Overview

    29.2. Africa Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Inactivated Influenza Vaccine Market Competitive Landscape And Company Profiles

    30.1. Inactivated Influenza Vaccine Market Competitive Landscape

    30.2. Inactivated Influenza Vaccine Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

    31. Inactivated Influenza Vaccine Market Other Major And Innovative Companies

    31.1. Abbott Laboratories

    31.2. Novartis International

    31.3. GlaxoSmithKline plc

    31.4. Viatris Inc.

    31.5. CSL

    31.6. Zydus Lifesciences Limited

    31.7. Sinovac Biotech Ltd.

    31.8. Bharat Biotech International Limited

    31.9. Dalian Aleph Biomedical Co. Ltd.

    31.10. Hualan Biological Bacterin Co. Ltd

    31.11. Changchun Biological

    31.12. Jiangsu gdk Biotechnology Co., Ltd.

    31.13. KM Biologics

    31.14. JoinHub Pharma

    31.15. Pharmika India Private Limited

    32. Global Inactivated Influenza Vaccine Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Inactivated Influenza Vaccine Market

    34. Recent Developments In The Inactivated Influenza Vaccine Market

    35. Inactivated Influenza Vaccine Market High Potential Countries, Segments and Strategies

    35.1 Inactivated Influenza Vaccine Market In 2029 - Countries Offering Most New Opportunities

    35.2 Inactivated Influenza Vaccine Market In 2029 - Segments Offering Most New Opportunities

    35.3 Inactivated Influenza Vaccine Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Inactivated Influenza Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Inactivated Influenza Vaccine Market, Sub-Segmentation Of Trivalent Inactivated Influenza Vaccine (TIIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Inactivated Influenza Vaccine Market, Sub-Segmentation Of Quadrivalent Inactivated Influenza Vaccine (QIIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Inactivated Influenza Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Inactivated Influenza Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Johnson & Johnson Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: Sanofi S.A. Financial Performance
  • Table 81: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Inactivated Influenza Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Inactivated Influenza Vaccine Market, Sub-Segmentation Of Trivalent Inactivated Influenza Vaccine (TIIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Inactivated Influenza Vaccine Market, Sub-Segmentation Of Quadrivalent Inactivated Influenza Vaccine (QIIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Inactivated Influenza Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Inactivated Influenza Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Inactivated Influenza Vaccine Market, Segmentation By Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Inactivated Influenza Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Inactivated Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Johnson & Johnson Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: Sanofi S.A. Financial Performance
  • Figure 81: AstraZeneca plc Financial Performance

Exploring Key Insights of the 3D Bioprinting Market: Growth Prospects, Emerging Trends, and Opportunities

Read More

Exploring Key Insights of the AI-based Surgical Robots Market: Growth Prospects, Emerging Trends, and Opportunities

Read More

Analyzing the Future of Arrhythmia Monitoring Devices Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

Read More

Unlocking the Future of the Autoinjectors Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Read More

Top Growth Trends in the Bifurcation Lesions Market: Key Insights and Opportunities for 2025-2034

Read More

How is the Bioprocess Containers Market Poised for Growth: Trends and Opportunities Through 2034

Read More

How is the Blood Collection Devices Market Poised for Growth: Trends and Opportunities Through 2034

Read More

Growth Opportunities and Trends in the Blood Culture Tests Market: Key Insights for 2025-2034

Read More

Adult Vaccines Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application (Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis), By End Users (Healthcare Firms, Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Travel Vaccines Global Market Report 2025 – By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By Composition (Mono Vaccines, Combination Vaccines), By Booking Channel (Online Booking, In-Person Booking), By Application (Domestic Travel, Outbound Travel) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inactivated Vaccines Global Market Report 2025 – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rabies Diagnostics Global Market Report 2025 – By Diagnostic Method( Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests), By Technology( ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies), By End-User( Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DTP Vaccines Market 2023 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End User (Hospitals, Clinics, Vaccination Centers), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Frequently Asked Questions

What is the definition of the Inactivated Influenza Vaccine market?

Inactivated influenza vaccine refers to a type of flu vaccine that contains viruses that have been killed or inactivated. It works by prompting the immune system to produce antibodies against the influenza virus. This vaccine is administered via injection to help prevent seasonal influenza infections. For further insights on the Inactivated Influenza Vaccine market, request a sample here

How will the Inactivated Influenza Vaccine market drivers and restraints affect the market dynamics? What forces will shape the Inactivated Influenza Vaccine industry going forward?

The Inactivated Influenza Vaccine market major growth driver - Expansion Of Government Vaccination Programs Driving Growth Of The Market Due To Enhancing Public Health Awareness. For further insights on the Inactivated Influenza Vaccine market, request a sample here

What is the forecast market size or the forecast market value of the Inactivated Influenza Vaccine market?

The Inactivated Influenza Vaccine market size has grown strongly in recent years. The inactivated influenza vaccine market size has grown strongly in recent years. It will grow from $6.62 billion in 2024 to $7.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased seasonal influenza outbreaks, government vaccination campaigns, rising elderly population, improved public health awareness, and expanded healthcare infrastructure. The inactivated influenza vaccine market size is expected to see strong growth in the next few years. It will grow to $9.99 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for quadrivalent vaccines, expanding immunization programs, growing focus on pandemic preparedness, technological advancements in vaccine production, and increasing global vaccine access. Major trends in the forecast period include a shift toward cell-based vaccine production, growing adoption of adjuvanted formulations, integration of influenza vaccines with COVID-19 boosters, rising demand in emerging markets, and personalized vaccine development strategies. For further insights on the Inactivated Influenza Vaccine market, request a sample here

How is the Inactivated Influenza Vaccine market segmented?

The inactivated influenza vaccine market covered in this report is segmented –
1) By Type Of Vaccine: Trivalent Inactivated Influenza Vaccine (TIIV), Quadrivalent Inactivated Influenza Vaccine (QIIV)
2) By Application: Children, Adolescence, Adults, Elderly
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Public Health Clinics
4) By End-User: Healthcare Providers, Individuals, Government Organizations, Pharmaceutical Companies
Subsegments:
1) Trivalent Inactivated Influenza Vaccine (TIIV): Egg-based Trivalent Inactivated Influenza Vaccine, Cell-based Trivalent Inactivated Influenza Vaccine, Adjuvanted Trivalent Inactivated Influenza Vaccine, High-dose Trivalent Inactivated Influenza Vaccine
2) Quadrivalent Inactivated Influenza Vaccine (QIIV): Egg-based Quadrivalent Inactivated Influenza Vaccine, Cell-based Quadrivalent Inactivated Influenza Vaccine, Adjuvanted Quadrivalent Inactivated Influenza Vaccine, Recombinant Quadrivalent Inactivated Influenza Vaccine, Pediatric Quadrivalent Inactivated Influenza Vaccine For further insights on the Inactivated Influenza Vaccine market, request a sample here

Which region has the largest share of the Inactivated Influenza Vaccine market? What are the other regions covered in the report?

North America was the largest region in the inactivated influenza vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated influenza vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Inactivated Influenza Vaccine market, request a sample here.

Who are the major players in the Inactivated Influenza Vaccine market?

Major companies operating in the inactivated influenza vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis International, GlaxoSmithKline plc, Viatris Inc., CSL, Zydus Lifesciences Limited, Sinovac Biotech Ltd., Bharat Biotech International Limited, Dalian Aleph Biomedical Co. Ltd., Hualan Biological Bacterin Co. Ltd, Changchun Biological, Jiangsu gdk Biotechnology Co., Ltd., KM Biologics, JoinHub Pharma, Pharmika India Private Limited. . For further insights on the Inactivated Influenza Vaccine market, request a sample here.

What are the key trends in the Inactivated Influenza Vaccine market?

Major trends in the Inactivated Influenza Vaccine market include Focus On Quadrivalent Inactivated Influenza Vaccines To Enhance Protection And Vaccine Efficacy In The Market. For further insights on the Inactivated Influenza Vaccine market, request a sample here.

What are the major opportunities in the Inactivated Influenza Vaccine market? What are the strategies for the Inactivated Influenza Vaccine market?

For detailed insights on the major opportunities and strategies in the Inactivated Influenza Vaccine market, request a sample here.

How does the Inactivated Influenza Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Inactivated Influenza Vaccine's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Inactivated Influenza Vaccine industry?

For detailed insights on the mergers and acquisitions in the Inactivated Influenza Vaccine industry, request a sample here.

What are the key dynamics influencing the Inactivated Influenza Vaccine market growth? SWOT analysis of the Inactivated Influenza Vaccine market.

For detailed insights on the key dynamics influencing the Inactivated Influenza Vaccine market growth and SWOT analysis of the Inactivated Influenza Vaccine industry, request a sample here.